Chitosan Modulates Inflammatory Responses in Rats Infected with Enterotoxigenic Escherichia coli

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Liu, Gang ^a,b   Chen, Shuai ^b   Guan, Guiping ^a   Tan, Jun ^a   Al Dhabi, Naif A ^c   Wang, Hongbing ^d   Duraipandiyan, Veeramuthu ^c   Fang, Jun ^a  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Hunan Institute of Animal and Veterinary Science   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; CYTOKINE; ENDOTOXIN; MESSENGER RNA; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; BODY WEIGHT; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; FLUID INTAKE; FOOD INTAKE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMISTRY; DIET; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; BACTERIAL LOAD; BODY WEIGHT; CHITOSAN; CYTOKINES; DIET; ENDOTOXINS; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INFLAMMATION; MICE; MICE, INBRED ICR; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 85008628455     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/7432845     Document Type: Article

References (25)

1. "Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries, " The Weekly Epidemiological Record, vol. 81, no. 11, pp. 97-104, 2006.
2. J. M. Fairbrother, E. Nadeau, and C. L. Gyles, "Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies, " Animal Health Research Reviews, vol. 6, no. 1, pp. 17-39, 2005.
3. J. S. Yoder, S. Cesario, V. Plotkin, X. Ma, K. Kelly-Shannon, and M. S. Dworkin, "Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness, " Clinical Infectious Diseases, vol. 42, no. 11, pp. 1513-1517, 2006.
4. P. Liu, X. S. Piao, P. A. Thacker et al., "Chito-oligosaccharide reduces diarrhea incidence and attenuates the immune response of weaned pigs challenged with Escherichia coli K88, " Journal of Animal Science, vol. 88, no. 12, pp. 3871-3879, 2010.
5. H. J. van der Fels-Klerx, L. F. Puister-Jansen, E. D. van Asselt, and S. L. G. E. Burgers, "Farmfactors associated with the use of antibiotics in pig production, " Journal of Animal Science, vol. 89, no. 6, pp. 1922-1929, 2011.
6. D. Xiao, Y. Wang, G. Liu et al., "Effects of chitosan on intestinal inflammation in weaned pigs challenged by enterotoxigenic Escherichia coli, " PLoS ONE, vol. 9, no. 8, Article ID e104192, 2014.
7. E. H. Choi, H. P. Yang, and H. S. Chun, "Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation, " Nutrition Research, vol. 32, no. 3, pp. 218-228, 2012.
8. I.-M. Fang, C.-M. Yang, and C.-H. Yang, "Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats, " Experimental Eye Research, vol. 130, pp. 38-50, 2015.
9. C. Qin, Y. Zhang, W. Liu, L. Xu, Y. Yang, and Z. Zhou, "Effects of chito-oligosaccharides supplementation on growth performance, intestinal cytokine expression, autochthonous gut bacteria and disease resistance in hybrid tilapia Oreochromis niloticus C× Oreochromis aureus D, " Fish & Shellfish Immunology, vol. 40, no. 1, pp. 267-274, 2014.
10. S.-H. Lee, M. Senevirathne, C.-B. Ahn, S.-K. Kim, and J.-Y. Je, "Factors affecting anti-inflammatory effect of chitooligosaccharides in lipopolysaccharides-induced RAW264.7 macrophage cells, " Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 23, pp. 6655-6658, 2009.
11. C. M. Yang, P. R. Ferket, Q. H. Hong et al., "Effect of chitooligosaccharide on growth performance, intestinal barrier function, intestinal morphology and cecal microflora in weaned pigs, " Journal of Animal Science, vol. 90, no. 8, pp. 2671-2676, 2012.
12. W. Ren, S. Chen, J. Yin et al., "Dietary arginine supplementation of mice alters the microbial population and activates intestinal innate immunity, " Journal of Nutrition, vol. 144, no. 6, pp. 988-995, 2014.
13. H. Liu, L. Song, Y. Cai, Y. Wang, and L. Yu, "Draft genome sequence of Escherichia coli strain SEC470, isolated froma piglet experiencing diarrhea, " Genome Announcements, vol. 4, no. 2, pp. e00088-16, 2016.
14. D. Xiao, W. Ren, P. Bin et al., "Chitosan lowers body weight through intestinal microbiota and reduces IL-17 expression via mTOR signalling, " Journal of Functional Foods, vol. 22, pp. 166-176, 2016.
15. W. Ren, S. Chen, L. Zhang et al., "Interferon tau affects mouse intestinal microbiota and expression of IL-17, " Mediators of Inflammation, vol. 2016, Article ID 2839232, 9 pages, 2016.
16. M. T. Abreu, E. T. Arnold, L. S. Thomas et al., "TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells, " Journal of Biological Chemistry, vol. 277, no. 23, pp. 20431-20437, 2002.
17. A. M. Neyrinck, L. B. Bindels, F. De Backer, B. D. Pachikian, P. D. Cani, and N. M. Delzenne, "Dietary supplementation with chitosan derived frommushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action, " International Immunopharmacology, vol. 9, no. 6, pp. 767-773, 2009.
18. J. Tourret, B. P. Willing, M. A. Croxen et al., "Small intestine early innate immunity response during intestinal colonization by Escherichia coli depends on its extra-intestinal virulence status, " PLOS ONE, vol. 11, no. 4, Article ID e0153034, 2016.
19. S. Liu, S. He, and M. Chiang, "Effects of long-term feeding of chitosan on postprandial lipid responses and lipid metabolism in a high-sucrose-diet-impaired glucose-tolerant rat model, " Journal of Agricultural and Food Chemistry, vol. 60, no. 17, pp. 4306-4313, 2012.
20. R. A. A. Muzzarelli, F. Orlandini, D. Pacetti et al., "Chitosan taurocholate capacity to bind lipids and to undergo enzymatic hydrolysis: an in vitro model, " Carbohydrate Polymers, vol. 66, no. 3, pp. 363-371, 2006.
21. S.-H. Jo, K.-S. Ha, K.-S. Moon et al., "Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model, " International Journal of Molecular Sciences, vol. 14, no. 7, pp. 14214-14224, 2013.
22. J.-G. Kim, S.-H. Jo, K.-S. Ha et al., "Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action, " BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 272, 2014.
23. A. A. Tayel, "Microbial chitosan as a biopreservative for fish sausages, " International Journal of Biological Macromolecules, vol. 93, pp. 41-46, 2016.
24. W. Ouyang, J. K. Kolls, and Y. Zheng, "The biological functions of T helper 17 cell effector cytokines in inflammation, " Immunity, vol. 28, no. 4, pp. 454-467, 2008.
25. E. Dima, O. Koltsida, P. Katsaounou et al., "Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD), " Cytokine, vol. 74, no. 2, pp. 313-317, 2015.